BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34470964)

  • 1. Respiratory Syncytial Virus Outbreaks Are Predicted after the COVID-19 Pandemic in Tokyo, Japan.
    Madaniyazi L; Seposo X; Ng CFS; Tobias A; Toizumi M; Moriuchi H; Yoshida LM; Hashizume M
    Jpn J Infect Dis; 2022 Mar; 75(2):209-211. PubMed ID: 34470964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan.
    Ujiie M; Tsuzuki S; Nakamoto T; Iwamoto N
    Emerg Infect Dis; 2021 Nov; 27(11):2969-2970. PubMed ID: 34388086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Nonpharmaceutical Interventions Implemented in Response to the COVID-19 Pandemic on Seasonal Respiratory Syncytial Virus: Analysis of Google Trends Data.
    Ravkin HD; Yom-Tov E; Nesher L
    J Med Internet Res; 2022 Dec; 24(12):e42781. PubMed ID: 36476385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of COVID-19 non-pharmaceutical interventions on the epidemiological dynamics of respiratory syncytial virus subtypes A and B.
    Holmdahl I; Bents SJ; Baker RE; Casalegno JS; Trovão NS; Park SW; Metcalf JE; Viboud C; Grenfell B
    Sci Rep; 2024 Jun; 14(1):14527. PubMed ID: 38914626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis.
    Leija-Martínez JJ; Esparza-Miranda LA; Rivera-Alfaro G; Noyola DE
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Epidemiological Analysis of Respiratory Syncytial Virus Detected in Tokyo, Japan in 2021 Season.
    Kasuya F; Mori K; Harada S; Kumagai R; Suzuki A; Amano A; Kosugi T; Hasegawa M; Nagashima M; Suzuki J; Sadamasu K
    Jpn J Infect Dis; 2023 Jan; 76(1):87-90. PubMed ID: 36184395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children.
    Lu Y; Chen Q; Ren S; Zhang Y; Yi L; Qian C; Shen J; Liu X; Jiang M; Wang B; Song J; Shao X; Zhang T; Tian J; Zhao G
    Influenza Other Respir Viruses; 2024 Apr; 18(4):e13291. PubMed ID: 38653953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa.
    Bents SJ; Viboud C; Grenfell BT; Hogan AB; Tempia S; von Gottberg A; Moyes J; Walaza S; Hansen C; Cohen C; Baker RE
    Influenza Other Respir Viruses; 2023 Dec; 17(12):e13229. PubMed ID: 38090227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RSV through the COVID-19 pandemic: Burden, shifting epidemiology, and implications for the future.
    Stein RT; Zar HJ
    Pediatr Pulmonol; 2023 Jun; 58(6):1631-1639. PubMed ID: 36811330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: Association with school closures.
    Billard MN; van de Ven PM; Baraldi B; Kragten-Tabatabaie L; Bont LJ; Wildenbeest JG
    Influenza Other Respir Viruses; 2022 Sep; 16(5):926-936. PubMed ID: 35733362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France.
    Fourgeaud J; Toubiana J; Chappuy H; Delacourt C; Moulin F; Parize P; Scemla A; Abid H; Leruez-Ville M; Frange P
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2389-2395. PubMed ID: 34347190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Potential Drivers for Respiratory Syncytial Virus Rebound During the Coronavirus Disease 2019 Pandemic.
    Li Y; Wang X; Cong B; Deng S; Feikin DR; Nair H
    J Infect Dis; 2022 Mar; 225(6):957-964. PubMed ID: 35030633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased human respiratory syncytial virus activity during the COVID-19 pandemic in Japan: an ecological time-series analysis.
    Wagatsuma K; Koolhof IS; Shobugawa Y; Saito R
    BMC Infect Dis; 2021 Aug; 21(1):734. PubMed ID: 34344351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. During the COVID-19 pandemic where has respiratory syncytial virus gone?
    Di Mattia G; Nenna R; Mancino E; Rizzo V; Pierangeli A; Villani A; Midulla F
    Pediatr Pulmonol; 2021 Oct; 56(10):3106-3109. PubMed ID: 34273135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global patterns of rebound to normal RSV dynamics following COVID-19 suppression.
    Thindwa D; Li K; Cooper-Wootton D; Zheng Z; Pitzer VE; Weinberger DM
    BMC Infect Dis; 2024 Jun; 24(1):635. PubMed ID: 38918718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-Depth Analysis of the Re-Emergence of Respiratory Syncytial Virus at a Tertiary Care Hospital in Germany in the Summer of 2021 after the Alleviation of Non-Pharmaceutical Interventions Due to the SARS-CoV-2 Pandemic.
    Hönemann M; Thiem S; Bergs S; Berthold T; Propach C; Siekmeyer M; Frille A; Wallborn T; Maier M; Pietsch C
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Characterization of Respiratory Syncytial Virus during 2022-23 Outbreak, Washington, USA.
    Goya S; Sereewit J; Pfalmer D; Nguyen TV; Bakhash SAKM; Sobolik EB; Greninger AL
    Emerg Infect Dis; 2023 Apr; 29(4):865-868. PubMed ID: 36878012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections.
    Baker RE; Park SW; Yang W; Vecchi GA; Metcalf CJE; Grenfell BT
    Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30547-30553. PubMed ID: 33168723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of non-pharmaceutical interventions on total disease burden in parsimonious epidemiological models.
    Fung T; Goh J; Chisholm RA
    J Theor Biol; 2024 Jun; 587():111817. PubMed ID: 38599566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection.
    Odumade OA; van Haren SD; Angelidou A
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S130-S135. PubMed ID: 35579506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.